Diane J Ordway
Overview
Explore the profile of Diane J Ordway including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1634
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belardinelli J, Verma D, Li W, Avanzi C, Wiersma C, Williams J, et al.
Sci Transl Med
. 2022 Feb;
14(633):eabj3860.
PMID: 35196022
A search for alternative treatments led to our interest in the two-component regulator DosRS, which, in , is required for the bacterium to establish a state of nonreplicating, drug-tolerant persistence...
2.
Selchow P, Ordway D, Verma D, Whittel N, Petrig A, Hobbie S, et al.
Antimicrob Agents Chemother
. 2021 Dec;
66(2):e0151021.
PMID: 34930031
Antibiotic therapy of infections caused by the emerging pathogen Mycobacterium abscessus is challenging due to the organism's inherent resistance to clinically available antimicrobials. The low bactericidal potency of currently available...
3.
Kazakova O, Racoviceanu R, Petrova A, Mioc M, Militaru A, Udrescu L, et al.
Int J Mol Sci
. 2021 Nov;
22(22).
PMID: 34830423
Twenty lupane type A-ring azepano-triterpenoids were synthesized from betulin and its related derivatives and their antitubercular activity against , mono-resistant MTB strains, and nontuberculous strains and Mycobacterium were investigated in...
4.
de Moura V, Verma D, Everall I, Brown K, Belardinelli J, Shanley C, et al.
Front Microbiol
. 2021 Aug;
12:706207.
PMID: 34335541
Chronic pulmonary infections caused by non-tuberculous mycobacteria of the complex (MABSC) are emerging as a global health problem and pose a threat to susceptible individuals with structural lung disease such...
5.
Bryant J, Brown K, Burbaud S, Everall I, Belardinelli J, Rodriguez-Rincon D, et al.
Science
. 2021 Apr;
372(6541).
PMID: 33926925
Although almost all mycobacterial species are saprophytic environmental organisms, a few, such as , have evolved to cause transmissible human infection. By analyzing the recent emergence and spread of the...
6.
Verma D, Chan E, Ordway D
Immunol Rev
. 2021 Mar;
301(1):48-61.
PMID: 33713043
Immunity against different Mycobacteria species targeting the lung requires distinctly different pulmonary immune responses for bacterial clearance. Many parameters of acquired and regulatory immune responses differ quantitatively and qualitatively from...
7.
Verma D, Chan E, Ordway D
Vaccines (Basel)
. 2020 Nov;
8(4).
PMID: 33207695
The global tuberculosis (TB) epidemic caused by the bacterial pathogen () continues unabated. The bacillus Calmette-Guérin (BCG) vaccination is widely utilized worldwide to protect against infection with . BCG vaccine...
8.
Wiersma C, Belardinelli J, Avanzi C, Angala S, Everall I, Angala B, et al.
ACS Infect Dis
. 2020 Jun;
6(8):2143-2154.
PMID: 32551551
Understanding the physiological processes underlying the ability of to become a chronic pathogen of the cystic fibrosis (CF) lung is important to the development of prophylactic and therapeutic strategies to...
9.
Chan E, Verma D, Ordway D
Curr Protoc Immunol
. 2020 Jun;
129(1):e98.
PMID: 32497414
This manuscript describes the infection of mice and guinea pigs with mycobacteria via various routes, as well as necropsy methods for the determination of mycobacterial loads within target organs. Additionally,...
10.
Daniel-Wayman S, Abate G, Barber D, Bermudez L, Coler R, Cynamon M, et al.
Am J Respir Crit Care Med
. 2018 Nov;
199(8):947-951.
PMID: 30428263
No abstract available.